SHIRE PLC - Blocklisting - Interim Review
November 23 2016 - 12:50PM
PR Newswire (US)
Block Listing SIX MONTHLY RETURN
November 23, 2016 - Shire
plc (LSE: SHP, NASDAQ: SHPG)
| Name of
applicant: |
Shire plc |
| Name of scheme: |
Shire Sharesave
Scheme |
| Period of return: |
From: |
May 23, 2016 |
To: |
November 22, 2016 |
| Balance of unallotted
securities under scheme(s) from previous return: |
184,913 |
| Plus: The
amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied
for): |
Nil |
| Less:
Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): |
302 |
| Equals:
Balance under scheme(s) not yet issued/allotted at end of
period: |
184,611 |
|
|
|
|
|
| Name of
applicant: |
Shire plc |
| Name of scheme: |
Shire Portfolio Share
Plan |
| Period of return: |
From: |
May 23, 2016 |
To: |
November 22, 2016 |
| Balance of unallotted
securities under scheme(s) from previous return: |
1,204,351 |
| Plus: The
amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied
for): |
Nil |
| Less:
Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): |
434,736 |
| Equals:
Balance under scheme(s) not yet issued/allotted at end of
period: |
769,615 |
|
|
|
|
|
| Name of
applicant: |
Shire plc |
| Name of scheme: |
Shire Employee Stock
Purchase Plan |
| Period of return: |
From: |
May 23, 2016 |
To: |
November 22, 2016 |
| Balance of unallotted
securities under scheme(s) from previous return: |
244,451 |
| Plus: The
amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied
for): |
Nil |
| Less:
Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): |
394 |
| Equals:
Balance under scheme(s) not yet issued/allotted at end of
period: |
244,057 |
|
|
|
|
|
| Name of
applicant: |
Shire plc |
| Name of scheme: |
Shire Long Term
Incentive Plan 2015 |
| Period of return: |
From: |
May 23, 2016 |
To: |
November 22, 2016 |
| Balance of unallotted
securities under scheme(s) from previous return: |
2,955,872 |
| Plus: The
amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied
for): |
Nil |
| Less:
Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): |
119,460 |
| Equals:
Balance under scheme(s) not yet issued/allotted at end of
period: |
2,836,412 |
|
|
|
|
|
| Name of
applicant: |
Shire plc |
| Name of scheme: |
Shire Global Employee
Stock Purchase Plan |
| Period of return: |
From: |
May 23, 2016 |
To: |
November 22, 2016 |
| Balance of unallotted
securities under scheme(s) from previous return: |
1,999,969 |
| Plus: The
amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied
for): |
Nil |
| Less:
Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): |
395,726 |
| Equals:
Balance under scheme(s) not yet issued/allotted at end of
period: |
1,604,243 |
|
|
|
|
|
| Name of
applicant: |
Shire plc |
| Name of scheme: |
Baxalta Exchange
Awards |
| Period of return: |
From: |
June 15, 2016 |
To: |
November 22, 2016 |
| Balance of unallotted
securities under scheme(s) from previous return: |
N/A |
| Plus: The
amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied
for): |
25,000,000 |
| Less:
Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): |
4,511,796 |
| Equals:
Balance under scheme(s) not yet issued/allotted at end of
period: |
20,488,204 |
|
|
|
|
|
| Name of contact: |
Sarah Rixon, Company Secretarial
Assistant |
| Telephone number of contact: |
01256 894000 |
For further information please
contact:
| Investor
Relations |
|
|
| Sarah Elton-Farr |
seltonfarr@shire.com |
+44 1256
894157 |
| Ian Karp |
ikarp@shire.com |
+1 781
482 9018 |
| Robert Coates |
rcoates@shire.com |
+44 1256
894874 |
| Media |
|
|
| Lisa Adler |
lisa.adler@shire.com |
+1-617
588 8607 |
| Debbi Ford |
debbi.ford@shire.com |
+1 617 949 9083 |
NOTES TO EDITORS
About Shire
Shire is the leading global biotechnology company focused on
serving people with rare diseases and other highly specialized
conditions. We strive to develop best-in-class products, many of
which are available in more than 100 countries, across core
therapeutic areas including Hematology, Immunology, Neuroscience,
Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal /
Internal Medicine / Endocrine and Hereditary Angioedema; and a
growing franchise in Oncology.
Our employees come to work every day with a shared mission: to
develop and deliver breakthrough therapies for the hundreds of
millions of people in the world affected by rare diseases and other
high-need conditions, and who lack effective therapies to live
their lives to the fullest.
www.shire.com
Copyright r 23 PR Newswire
Shire Plc ADS, Each Representing Three Ordinary Shares (NASDAQ:SHPG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Shire Plc ADS, Each Representing Three Ordinary Shares (NASDAQ:SHPG)
Historical Stock Chart
From Apr 2023 to Apr 2024
